TGFβ contributes to metastatic progression of carcinomas, by promoting EMT, suppressing anti‐tumoral immune responses, and by enhancing the differentiation of cancer‐associated fibroblasts and the growth of the tumor vasculature (Bierie & Moses, 2006). This evidence concerns the gene TGFB1 and cancer.